Join the 200th Anniversary Celebration

Original Article

Use of Multiple Drugs among Adolescents Who Use Anabolic Steroids

Robert H. DuRant, Vaughn I. Rickert, Carolyn Seymore Ashworth, Cheryl Newman, and Gregory Slavens

N Engl J Med 1993; 328:922-926April 1, 1993

Abstract

Background

Because adolescent users of anabolic steroids are concerned with increasing muscle size and strength, they may be unique among substance users and unlikely to use other drugs. Alternatively, if the factors that cause the use of anabolic steroids are similar to those associated with the use of other substances, adolescents who use anabolic steroids would be expected to report use of other drugs as well.

Methods

We administered a questionnaire based on the 1989 Secondary School Health Risk Survey and the 1990 Youth Risk Behavior Survey of the Centers for Disease Control and Prevention to 1881 students enrolled in compulsory health-science classes (mean [±SD] age, 14.9 ±1.0 years) in the Richmond County, Georgia, school system.

Results

A higher percentage of boys (6.5 percent) than girls (1.9 percent, P ≤ 0.001) reported using anabolic steroids without a doctor's prescription. Among ninth-grade students, 5.4 percent of boys and 1.5 percent of girls reported using anabolic steroids (P ≤ 0.001). Among users of anabolic steroids, 25 percent reported sharing needles to inject drugs. The frequency of anabolic-steroid use was significantly (P<0.001) associated with the frequency of use in the previous 30 days of cocaine (r = 0.44), injectable drugs, alcohol (r = 0.23), marijuana (r = 0.42), cigarettes (r = 0.25), and smokeless tobacco (r = 0.40). On the basis of multiple regression analysis, the use of marijuana, shared needles, smokeless tobacco, and cocaine accounted for 33 percent of the variation in anabolic-steroid use among the ninth-grade students.

Conclusions

In our study, adolescent users of anabolic steroids were likely to use other drugs as well, and many were sharing needles.

Media in This Article

Table 1Characteristics of 1881 Students in Ninth-Grade Health-Science Classes and Frequency of Anabolic-Steroid Use.
Table 2Substance Use and Risk-Taking Behavior with Regard to AIDS and HIV, as Reported by 1881 Adolescents.
Article

It is estimated that 1 million people in the United States are spending more than $100 million a year on black-market anabolic steroids1-3. Habitual use of anabolic steroids to enhance muscle size for cosmetic reasons and to improve strength and endurance for competitive purposes is increasing4. Some 250,000 U.S. high-school seniors have used anabolic steroids, and the use of anabolic steroids by adolescents is increasing3-10. Five to 11.1 percent of males and as many as 2.5 percent of females surveyed have used anabolic steroids4,10. Adolescents who use these substances most frequently are apt to be participating in football and wrestling. However, Johnson et al.8 reported a small portion of male adolescents who used anabolic steroids without engaging in activities such as weight lifting to promote increases in muscle size. Buckley et al.7 found that the students who used anabolic steroids frequently were likely to have begun to use these drugs at a younger age.

These studies suggest that adolescents who begin using anabolic steroids at young ages often continue to use several types of anabolic steroids for extended periods and that they share behavior, perceptions, and opinions that are consistent with habituation or psychological dependence7,10-13. Steroids affect mood as well as the physique and may induce complications similar to those associated with other misused drugs, such as cocaine, marijuana, and alcohol3,12. The relation of anabolic-steroid use to other drug use remains unclear. Users of steroids may be unique among substance users because they often have an attitude that the body is a “temple” and do not use alcohol and marijuana because they believe that these substances will harm their health10. Alternatively, if the mechanisms of anabolic-steroid use are similar to those of other substance use,14 users of anabolic steroids would also be expected to report the use of multiple drugs.

The protocol of injecting steroids represents an increased level of commitment to drug use, which often leads anabolic-steroid users to engage in behavior similar to that of other adolescent substance abusers11. For example, since insulin needles cannot be used for steroid injections, adolescents must obtain larger-gauge needles through the black market11. As with other illicit, injectable drugs, the use of anabolic steroids by adolescents becomes an even more critical health issue because of its potential for contributing to the spread of the human immunodeficiency virus (HIV) through the sharing of contaminated needles15,16.

In this study we examined the relation of anabolicsteroid use to the use of other drugs, including cocaine, marijuana, alcohol, cigarettes, and smokeless tobacco. In addition, we sought to determine the degree to which young adolescents reported the use of injectable drugs and the percentage that reported sharing needles. Finally, we also attempted to evaluate the relation between previous education about HIV and the use of anabolic steroids.

Methods

Subjects

This study was approved by the Human Assurance Committee of the Medical College of Georgia and the Board of Education of Richmond County, Georgia. In November 1990, we administered an anonymous standardized questionnaire, based on the questionnaire used by the Centers for Disease Control and Prevention (CDC) for the 1989 Secondary School Health Risk Survey,17-19 to all students (n = 1881) in the compulsory ninth-grade health-science classes in Richmond County. The characteristics of the students are described in Table 1Table 1Characteristics of 1881 Students in Ninth-Grade Health-Science Classes and Frequency of Anabolic-Steroid Use.. Like the National Center for Health Statistics, the CDC uses the following classifications for race: black, white, Native American or Alaskan Native, Asian or Pacific Islander, and other. Because people with a Hispanic ethnic background often belong to different racial groups, membership in the Hispanic or Latino ethnic group is measured with a separate question20. Most of the students we surveyed were in the ninth grade, but other students who had not yet taken health education were also in the class. The mean (±SD) age of the students was 14.9 ±1.0 years.

Questionnaire

We used a modified version of the 1989 edition of the CDC's Secondary School Health Risk Survey21-23. This survey was designed for the school-based epidemiologic surveillance of adolescents' knowledge, attitudes, and behaviors related to health risks and has not been tested for test-retest reliability24. However, acceptable levels of internal reliability have been found for most of the scales in the questionnaire21-26. Ten questions assessing the frequency of substance use from the CDC's 1990 Youth Risk Behavior Survey were added to the questionnaire18. These two questionnaires have been used extensively by the CDC to measure risk-taking behavior among adolescents attending public schools.

Variables

Two questions from the 1990 CDC Youth Risk Behavior Survey asked respondents whether they had ever “injected (shot up) cocaine, heroin, or other illegal drugs into your body” and whether they had done so in the past 30 days. Subjects were also asked “In the last 30 days, have you shared needles used to inject (shoot up) any drugs?” Two questions asked how many times respondents had used any form of cocaine, including powder, crack, or freebase, “during your life” and “during the last 30 days” (Table 2Table 2Substance Use and Risk-Taking Behavior with Regard to AIDS and HIV, as Reported by 1881 Adolescents.). Four questions assessed the use of alcohol, marijuana, cigarettes, and smokeless tobacco during the previous month. Anabolic-steroid use was assessed with the following question: “During your life, how many times have you taken steroid pills or shots without a doctor's prescription?” (Table 2). We also asked whether the student had received education about the acquired immunodeficiency syndrome (AIDS) and HIV in school before the introduction of the current curriculum. Sixty-eight percent (n = 1274) responded yes to this question. The frequency of behavior placing the adolescent at risk for AIDS or HIV was assessed by asking, “During the last month, how many times have you engaged in any behavior that would increase your chance of getting the AIDS/HIV infection?” with forced-choice responses ranging from 0 times to 9 or more times (Table 2). This was placed as the last item in the questionnaire, so the students' responses to this question would be prompted by all previous questions about knowledge, attitudes, and behavior.

Statistical Analysis

Both continuous and ordinal data are summarized as means ±SD for simplicity of interpretation. Because the AIDS-HIV risk-taking scale and the scales assessing substance use were positively skewed, the means and standard deviations should be interpreted with caution. Moreover, since the variables were measured on ordinal scales and were not normally distributed, pairwise associations were tested with the Spearman rank-correlation coefficient (r) and chi-square tests. All variables found to be significantly associated with the frequency of use of anabolic steroids were then analyzed with stepwise multiple regression analysis, with forward inclusion of the independent variables27.

Categorical variables were treated as indicator variables in the regression model. The change in the R2 (the percentage of the variation explained) when each variable was added to the model was examined to assess the clustering of substance use by anabolic-steroid users. Because of the time frames attached to the questions measuring the use of anabolic steroids as compared with the use of other substances, the correlation and regression analyses should be reviewed as covariational relations and not as cause-and-effect relations. The regression analysis was conducted only on the data for the ninth-grade students.

Results

The proportion of students who reported that they had ever used anabolic steroids was 4.2 percent. Among those who had used anabolic steroids, the frequency of use was evenly distributed across the categories, ranging from 1 to 2 times to 40 or more times (Table 1). A significantly higher percentage of boys than girls and of Hispanic than non-Hispanic adolescents reported the use of anabolic steroids (Table 3Table 3Frequency of Use of Anabolic Steroids among 1813 Adolescents According to Sex, Hispanic Background, Previous AIDS-HIV Education, and Injection-Drug Use.). The Hispanic students were distributed among all four racial groups (Table 1). When we controlled for racial group, the difference in anabolic-steroid use between Hispanics and non-Hispanics was significant (P ≤ 0.001) only among white students. Students who had previously received education about AIDS and HIV in school were less likely to have used anabolic steroids. Students in the 9th grade reported less use of anabolic steroids than students in the 10th through 12th grades. However, the correlation between the frequency of use of anabolic steroids and the grade in school was low (r = 0.13, P<0.001). Among the ninth-grade students, 5.4 percent of the boys and 1.5 percent of the girls (P<0.001) reported the use of anabolic steroids. No other racial or demographic differences were associated with the use of anabolic steroids in this sample of students.

Among the students who had used anabolic steroids, 24.7 percent reported that they had shared needles to inject drugs during the previous 30 days. However, 30.6 percent of anabolic-steroid users who had not received school-based education about AIDS and HIV had shared needles, as compared with 18.9 percent of anabolic-steroid users who had received such education.

In general, the more frequently these adolescents used anabolic steroids, the more likely they were to use one or more other drugs (Table 4Table 4Spearman Rank-Correlation Coefficients (r) for Reported Substance Use and Risk-Taking Behavior with Regard to AIDS and HIV.). The use of anabolic steroids was moderately strongly associated with the frequency of use of cocaine, marijuana, and smokeless tobacco, as indicated by correlation coefficients ranging from 0.40 to 0.44. Weaker correlations were found with the frequency of cigarette smoking, alcohol use, AIDS-HIV risk-taking behavior, and age (Table 4). Anabolic-steroid use was also significantly associated with injection-drug use and the use of shared needles to inject drugs during the previous 30 days (Table 3).

Among the ninth-grade students only, all variables found to be significantly associated with the use of anabolic steroids were analyzed with multiple regression analysis to determine which group of factors explained the highest percentage of the variation in the frequency of use (Table 5Table 5Multiple Regression Analysis of Frequency of Anabolic Steroid Use in the Subsample of Ninth-Grade Students.). Five variables explained significant amounts of additional variation in anabolic-steroid use when added to the regression model. This analysis revealed substantial clustering of other drug-use behaviors among users of anabolic steroids. Cocaine use was the strongest factor covarying with anabolic-steroid use, explaining 20.4 percent of the variation in the frequency of use. In descending order of magnitude, the following variables also explained significant amounts of additional variation in anabolic-steroid use (P<0.001): marijuana use (7.6 percent), shared-needle use (3.5 percent), and smokeless-tobacco use (1.2 percent). Previous AIDS-HIV education was a significant predictor of anabolic-steroid use, but the magnitude of the change in R2 was too small to be meaningful. The first four variables in the model explained 32.7 percent of the variation in the frequency of use of anabolic steroids.

Discussion

In previous studies, 5 to 11 percent of adolescent boys and 1 to 2.5 percent of adolescent girls reported using anabolic steroids4-10. In our study, 6.5 percent of boys and 1.9 percent of girls reported the use of anabolic steroids. Among ninth-grade students, 5.4 percent of boys and 1.5 percent of girls reported use of anabolic steroids. Our data also suggest that a substantial number of young adolescents have used injection drugs, probably anabolic steroids, and one quarter of anabolic-steroid users have shared needles to inject drugs during the past 30 days. Earlier studies suggested that those who first use anabolic steroids by 15 years of age make up the largest single group of high-school seniors who report the use of these drugs7,11. Our data confirm these reports but suggest that anabolic-steroid use probably begins even earlier.

Our study relied on the validity of the students' own reports as measures of their drug use. We used a questionnaire that had been developed by the CDC and used extensively in school-based populations. That the prevalence of use of anabolic steroids in this population was similar to the rates found in other studies adds credibility to our results.

Almost one quarter of the students who reported using anabolic steroids in our study also reported sharing needles, a practice that places them at risk for HIV and other viral infections. Anabolic-steroid users who reported that they had previously received education about AIDS in school reported sharing needles less frequently than those who had not received such education about AIDS and HIV. Thus, there are young adolescents who are using injectable forms of anabolic steroids without recognizing the risk of HIV transmission. They may not perceive themselves as being at risk for infection because they perceive themselves as invulnerable. They may also believe that they will not become infected because the people with whom they are sharing needles are not seen to be “real” drug users, such as those who inject heroin. Finally, users may believe they are at low risk for infection because steroids are not harmful but, rather, health-enhancing7,10,11. Regardless of the explanation for the sharing of needles, our data confirm that this practice may serve as a route for the transmission of HIV among adolescents15,16.

We found significant associations between the use of anabolic steroids and the use of marijuana, cocaine, cigarettes, smokeless tobacco, and alcohol. Particularly disturbing were the strong relations we found between the use of anabolic steroids and the concomitant use of mood-altering substances. The relation between smokeless tobacco products and anabolic steroids has been documented before28.

Educational interventions concerning the effects of anabolic steroids are just beginning to be described in the literature29-33. Like similar strategies to decrease alcohol consumption among adolescents,34 interventions that only provide information about the negative effects of anabolic steroids have little effect. Behavioral change and interventions designed to teach risk-reduction and risk-avoidance skills that are specifically targeted to these users must be employed, since many of them are likely to engage in more than one type of high-risk behavior.

Source Information

From the Departments of Pediatrics (R.H.D., G.S.) and Internal Medicine (C.N.), Medical College of Georgia, Augusta; the Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock (V.I.R.); and the Department of Pediatrics, University of Alabama at Birmingham (C.S.A.).

Address reprint requests to Dr. DuRant at the Section of General Pediatrics and Adolescent Medicine, Department of Pediatrics, CE-112, Medical College of Georgia, Augusta, GA 30912.

References

References

  1. 1

    Taylor WN, Black AB. Pervasive anabolic steroid use among health club athletes. Ann Sports Med 1987;3:155-159

  2. 2

    Burkett LN, Falduto MT. Steroid use by athletes in a metropolitan area. Phys Sports Med 1984;12:69-74

  3. 3

    Giannini AJ, Miller N, Kocjan DK. Treating steroid abuse: a psychiatric perspective. Clin Pediatr (Bologna) 1991;30:538-542
    CrossRef

  4. 4

    Committee on the Judiciary, U.S. Senate. Drug misuse: steroids and human growth hormone: report to the chairman. Washington, D.C.: Government Printing Office, 1989. (Publication no. GAO/HRD-89-109).

  5. 5

    Johnson MD. Anabolic steroid use in adolescent athletes. Pediatr Clin North Am 1990;37:1111-1123
    Web of Science | Medline

  6. 6

    Terney R, McLain LG. The use of anabolic steroids in high school students. Am J Dis Child 1990;144:99-103
    Web of Science | Medline

  7. 7

    Buckley WE, Yesalis CE III, Freidl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988;260:3441-3445
    CrossRef | Web of Science | Medline

  8. 8

    Johnson MD, Jay MS, Shoup B, Rickert VI. Anabolic steroid use by male adolescents. Pediatrics 1989;83:921-924
    Web of Science | Medline

  9. 9

    Windsor R, Dumitru D. Prevalence of anabolic steroid use by male and female adolescents. Med Sci Sports Exerc 1989;21:494-497
    Web of Science | Medline

  10. 10

    Komoroski EM, Rickert VI. Adolescent body image and attitudes to anabolic steroid use. Am J Dis Child 1992;146:823-828
    Web of Science | Medline

  11. 11

    Yesalis CE, Streit AL, Vicary JR, Friedl KE, Brannon D, Buckley W. Anabolic steroid use: indications of habituation among adolescents. J Drug Educ 1989;19:103-116
    CrossRef | Web of Science | Medline

  12. 12

    Kashkin KB, Kleber HD. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA 1989;262:3166-3170
    CrossRef | Web of Science | Medline

  13. 13

    Pope HG Jr, Katz DL, Champoux R. Anabolic-androgenic steroid use among 1,010 college men. Phys Sports Med 1988;16:75-81
    Web of Science

  14. 14

    Jessor R. Adolescent development and behavioral health. In: Matarazzo JD, Weiss SM, Herd JA, Miller NE, Weiss SM, eds. Behavioral health: a handbook of health enhancement and disease prevention. New York: Wiley, 1984:69-90.

  15. 15

    Sklarek HM, Mantovani RP, Erens E, Heisler D, Niederman MS, Fein AM. AIDS in a bodybuilder using anabolic steroids. N Engl J Med 1984;311:1701-1701
    Web of Science | Medline

  16. 16

    Nemechek PM. Anabolic steroid users -- another potential risk group for HIV infection. N Engl J Med 1991;325:357-357
    Web of Science | Medline

  17. 17

    Anderson JE, Kann L, Holtzman D, Arday S, Truman B, Kolbe LJ. HIV/AIDS knowledge and sexual behavior among high school students. Fam Plann Perspect 1990;22:252-255
    CrossRef | Medline

  18. 18

    Kolbe LJ. An epidemiological surveillance system to monitor the prevalence of youth behaviors that most affect health. Health Educ 1990;21:44-48

  19. 19

    Kann L, Nelson GD, Jones JT, Kolbe LJ. Establishing a system of complementary school-based surveys to annually assess HIV-related knowledge, beliefs, and behaviors among adolescents. J Sch Health 1989;59:55-58
    CrossRef | Web of Science | Medline

  20. 20

    DuRant RH, Pendergrast R, Seymore C. Sexual behavior among Hispanic female adolescents in the United States. Pediatrics 1990;85:1051-1058
    Web of Science | Medline

  21. 21

    DuRant RH, Ashworth CS, Newman C, Gaillard G. High school students' knowledge of HIV/AIDS and perceived risk of currently having AIDS. J Sch Health 1992;62:59-63
    CrossRef | Web of Science | Medline

  22. 22

    Ashworth CS, DuRant RH, Newman C, Gaillard G. An evaluation of a school-based AIDS/HIV education program for high school students. J Adolesc Health 1992;13:582-588
    CrossRef | Web of Science | Medline

  23. 23

    Pendergrast RA Jr, DuRant RH, Gaillard GL. Attitudinal and behavioral correlates of condom use in urban adolescent males. J Adolesc Health 1992;13:133-139
    CrossRef | Web of Science | Medline

  24. 24

    DuRant RH, Ashworth CS, Newman C, McGill L, Rabun C, Baranowski T. AIDS/HIV knowledge level and perceived chance of having HIV among rural adolescents. J Adolesc Health 1992;13:499-505
    CrossRef | Web of Science | Medline

  25. 25

    Newman C, DuRant RH, Ashworth CS, Gaillard G. An evaluation of a school-based AIDS/HIV education program for young adolescents. J AIDS Educ (in press).

  26. 26

    Diclemente RJ. Predictors of HIV-preventive sexual behavior in a high-risk adolescent population: the influence of perceived peer norms and sexual communication on incarcerated adolescents' consistent use of condoms. J Adolesc Health 1991;12:385-390
    CrossRef | Web of Science | Medline

  27. 27

    SPSSx user's guide. 2nd ed. Chicago: SPSS, 1986:663-86, 857-72.

  28. 28

    Botvin GJ, Baker E, Tortu S, Dusenbury L, Gessula J. Smokeless tobacco use among adolescents: correlates and concurrent predictors. J Dev Behav Pediatr 1989;10:181-186
    CrossRef | Web of Science | Medline

  29. 29

    Hallagan JB, Hallagan LF, Snyder MB. Anabolic-androgenic steroid use by athletes. N Engl J Med 1989;321:1042-1045
    Full Text | Web of Science | Medline

  30. 30

    Goldberg L, Bosworth E, Elliot DL, Bents R. Use of anabolic-androgenic steroids by athletes. N Engl J Med 1990;322:775-776
    Web of Science | Medline

  31. 31

    Hallagan JB, Hallagan LF, Snyder MB. Use of anabolic-androgenic steroids by athletes. N Engl J Med 1990;322:776-776
    Full Text | Web of Science | Medline

  32. 32

    Goldberg L, Bents R, Bosworth E, Trevisan L, Elliot DL. Anabolic steroid education and adolescents: do scare tactics work? Pediatrics 1991;87:283-286
    Web of Science | Medline

  33. 33

    Goldberg L, Bosworth EE, Bents RT, Trevisan L. Effect of an anabolic steroid education program on knowledge and attitudes of high school football players. J Adolesc Health Care 1990;11:210-214
    CrossRef | Medline

  34. 34

    Rickert VI, Jay MS, Gottlieb AA. Adolescent wellness: facilitating compliance in social morbidities. Med Clin North Am 1990;74:1135-1148
    Web of Science | Medline

Citing Articles (78)

Citing Articles

  1. 1

    Bernd Lenz, Christian P. Müller, Christina Stoessel, Wolfgang Sperling, Teresa Biermann, Thomas Hillemacher, Stefan Bleich, Johannes Kornhuber. (2011) Sex hormone activity in alcohol addiction: Integrating organizational and activational effects. Progress in Neurobiology
    CrossRef

  2. 2

    Tom Hildebrandt, Rachel Yehuda, Lauren Alfano. (2011) What can allostasis tell us about anabolic–androgenic steroid addiction?. Development and Psychopathology 23:03, 907-919
    CrossRef

  3. 3

    Andrea Petróczi, Jason Mazanov, Declan P Naughton. (2011) Inside athletes' minds: Preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping. Substance Abuse Treatment, Prevention, and Policy 6:1, 10
    CrossRef

  4. 4

    Beth A. Costine, Joseph G. Oberlander, Matthew C. Davis, Carlos A.A. Penatti, Donna M. Porter, Robert N. Leaton, Leslie P. Henderson. (2010) Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse. Psychoneuroendocrinology 35:10, 1473-1485
    CrossRef

  5. 5

    Lena Lundholm, Kerstin Käll, Sussi Wallin, Ingemar Thiblin. (2010) Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug and Alcohol Dependence 111:3, 222-226
    CrossRef

  6. 6

    Donald E. Greydanus, Dilip R. Patel. (2010) Sports Doping in the Adolescent: The Faustian Conundrum of Hors De Combat. Pediatric Clinics of North America 57:3, 729-750
    CrossRef

  7. 7

    Gen Kanayama, James I. Hudson, Harrison G. Pope. (2010) Illicit anabolic–androgenic steroid use. Hormones and Behavior 58:1, 111-121
    CrossRef

  8. 8

    Richard H. Melloni, Lesley A. Ricci. (2010) Adolescent exposure to anabolic/androgenic steroids and the neurobiology of offensive aggression: A hypothalamic neural model based on findings in pubertal Syrian hamsters. Hormones and Behavior 58:1, 177-191
    CrossRef

  9. 9

    AnaChristina E. Minerly, Hui Bing K. Wu, Karen M. Weierstall, Tipyamol Niyomchai, Lynne Kemen, Shirzad Jenab, Vanya Quinones-Jenab. (2010) Testosterone differentially alters cocaine-induced ambulatory and rearing behavioral responses in adult and adolescent rats. Pharmacology Biochemistry and Behavior 94:3, 404-409
    CrossRef

  10. 10

    Gen Kanayama, Kirk J. Brower, Ruth I. Wood, James I. Hudson, Harrison G. Pope Jr. (2009) Anabolicandrogenic steroid dependence: an emerging disorder. Addiction 104:12, 1966-1978
    CrossRef

  11. 11

    Johan Alsiö, Carolina Birgner, Lars Björkblom, Pernilla Isaksson, Lena Bergström, Helgi B. Schiöth, Jonas Lindblom. (2009) Impact of Nandrolone Decanoate on Gene Expression in Endocrine Systems Related to the Adverse Effects of Anabolic Androgenic Steroids. Basic & Clinical Pharmacology & Toxicology 105:5, 307-314
    CrossRef

  12. 12

    Lebur Rohman. (2009) The Relationship Between Anabolic Androgenic Steroids and Muscle Dysmorphia: A Review. Eating Disorders 17:3, 187-199
    CrossRef

  13. 13

    Sean Esteban McCabe, Kirk J. Brower, Brady T. West, Toben F. Nelson, Henry Wechsler. (2007) Trends in non-medical use of anabolic steroids by U.S. college students: Results from four national surveys. Drug and Alcohol Dependence 90:2-3, 243-251
    CrossRef

  14. 14

    Julie M. Kerr, Joseph A. Congeni. (2007) Anabolic-Androgenic Steroids: Use and Abuse in Pediatric Patients. Pediatric Clinics of North America 54:4, 771-785
    CrossRef

  15. 15

    G. Patrick Daubert, Vincent H. Mabasa, Vivian W. Y. Leung, Cynthia Aaron. (2007) Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. Journal of Medical Toxicology 3:2, 56-60
    CrossRef

  16. 16

    Lina A. Ricciardelli, Marita P. McCabe, Robert J. Williams, J. Kevin Thompson. (2007) The role of ethnicity and culture in body image and disordered eating among males. Clinical Psychology Review 27:5, 582-606
    CrossRef

  17. 17

    Gen Kanayama, Matthew Boynes, James I. Hudson, Alison E. Field, Harrison G. Pope. (2007) Anabolic steroid abuse among teenage girls: An illusory problem?. Drug and Alcohol Dependence 88:2-3, 156-162
    CrossRef

  18. 18

    Bodo Melnik, Thomas Jansen, Stephan Grabbe. (2007) Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. JDDG 5:2, 110-117
    CrossRef

  19. 19

    H. Nielens, M.-P. Hermans. (2007) Dopaje y patologa osteoarticular: fisiologa y riesgos. EMC - Aparato Locomotor 40:2, 1-8
    CrossRef

  20. 20

    David M. Martin, David A. Baron, Mark S. Gold. (2006) A Review of Performance-Enhancing Drugs in Professional Sports and Their Spread to Amateur Athletics, Adolescents, and Other At-Risk Populations. Journal of Addictive Diseases 25:sup1, 5-15
    CrossRef

  21. 21

    Perikles Simon, Heiko Striegel, Fabian Aust, Klaus Dietz, Rolf Ulrich. (2006) Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction 101:11, 1640-1644
    CrossRef

  22. 22

    Youichiro Morita, Ichiro Iwamoto, Nobuhisa Mizuma, Tomoki Kuwahata, Takashi Matsuo, Mitsuhiro Yoshinaga, Tsutomu Douchi. (2006) Precedence of the shift of body-fat distribution over the change in body composition after menopause. Journal of Obstetrics and Gynaecology Research 32:5, 513-516
    CrossRef

  23. 23

    LARS WICHSTR??M. (2006) Predictors of Future Anabolic Androgenic Steroid Use. Medicine & Science in Sports & Exercise 38:9, 1578-1583
    CrossRef

  24. 24

    Tonya L. Dodge, James J. Jaccard. (2006) The Effect of High School Sports Participation on the Use of Performance-Enhancing Substances in Young Adulthood. Journal of Adolescent Health 39:3, 367-373
    CrossRef

  25. 25

    Evelyne Célérier, Therese Ahdepil, Helena Wikander, Fernando Berrendero, Fred Nyberg, Rafael Maldonado. (2006) Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence. Neuropharmacology 50:7, 788-806
    CrossRef

  26. 26

    Susan M. Yussman, Karen M. Wilson, Jonathan D. Klein. (2006) Herbal products and their association with substance use in adolescents. Journal of Adolescent Health 38:4, 395-400
    CrossRef

  27. 27

    John M. Tokish. 2006. Anabolic Steroids and Other Performance-Enhancing Substances in the Adolescent Athlete. , 105-112.
    CrossRef

  28. 28

    Heiko Striegel, Perikles Simon, Steffen Frisch, Kai Roecker, Klaus Dietz, Hans-Hermann Dickhuth, Rolf Ulrich. (2006) Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug and Alcohol Dependence 81:1, 11-19
    CrossRef

  29. 29

    Yoel Antonio Rojas-Ortiz, Valerie Rundle-González, Isamar Rivera-Ramos, Juan Carlos Jorge. (2006) Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17α-methyltestosterone in adult mice. Hormones and Behavior 49:1, 123-128
    CrossRef

  30. 30

    Linn Goldberg, Diane L. Elliot. (2005) Preventing Substance Use Among High School Athletes. Journal of Applied School Psychology 21:2, 63-87
    CrossRef

  31. 31

    R. C.W. Hall. (2005) Psychiatric Complications of Anabolic Steroid Abuse. Psychosomatics 46:4, 285-290
    CrossRef

  32. 32

    Ryan C. W. Hall, Richard C. W. Hall. (2005) Abuse of Supraphysiologic Doses of Anabolic Steroids. Southern Medical Journal 98:5, 550-555
    CrossRef

  33. 33

    Brychan M. Clark, Richard S. Schofield. (2005) Dilated Cardiomyopathy and Acute Liver Injury Associated with Combined Use of Ephedra, γ-Hydroxybutyrate, and Anabolic Steroids. Pharmacotherapy 25:5, 756-761
    CrossRef

  34. 34

    Barry Dickinson, Linn Goldberg, Diane Elliot, Daniel Spratt, Alan D. Rogol, Lisa H. Fish. (2005) Hormone Abuse in Adolescents and Adults. The Endocrinologist 15:2, 115-125
    CrossRef

  35. 35

    Amy M. Duhig, Dana A. Cavallo, Sherry A. McKee, Tony P. George, Suchitra Krishnan-Sarin. (2005) Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addictive Behaviors 30:2, 271-283
    CrossRef

  36. 36

    MARILYN Y. McGINNIS. (2004) Anabolic Androgenic Steroids and Aggression: Studies Using Animal Models. Annals of the New York Academy of Sciences 1036:1, 399-415
    CrossRef

  37. 37

    Michael J. Furlong, Jill D. Sharkey, Michael P. Bates, Douglas C. Smith. (2004) An Examination of the Reliability, Data Screening Procedures, and Extreme Response Patterns for the Youth Risk Behavior Surveillance Survey. Journal of School Violence 3:2-3, 109-130
    CrossRef

  38. 38

    Robert B. Millman, Emil J. Ross. (2003) Steroid and Nutritional Supplement Use in Professional Athletes. The American Journal on Addictions 12, S48-S54
    CrossRef

  39. 39

    Tsutomu Douchi, Shoichiro Kosha, Hirofumi Uto, Toshimichi Oki, Mitsuhiro Nakae, Nobuyuki Yoshimitsu, Yukihiro Nagata. (2003) Precedence of bone loss over changes in body composition and body fat distribution within a few years after menopause. Maturitas 46:2, 133-138
    CrossRef

  40. 40

    Gen Kanayama, Harrison G. Pope, Geoffrey Cohane, James I. Hudson. (2003) Risk factors for anabolic-androgenic steroid use among weightlifters: a case–control study. Drug and Alcohol Dependence 71:1, 77-86
    CrossRef

  41. 41

    2003. References. , 116-136.
    CrossRef

  42. 42

    Evelyne Célérier, Maryam T Yazdi, Anna Castañé, Sandy Ghozland, Fred Nyberg, Rafael Maldonado. (2003) Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. European Journal of Pharmacology 465:1-2, 69-81
    CrossRef

  43. 43

    Kathleen E. Miller, Grace M. Barnes, Donald F. Sabo, Merrill J. Melnick, Michael P. Farrell. (2002) Anabolic-Androgenic Steroid Use and Other Adolescent Problem Behaviors: Rethinking the Male Athlete Assumption. Sociological Perspectives 45:4, 467-489
    CrossRef

  44. 44

    S Martı́nez-Sanchis, C.M.G Aragon, A Salvador. (2002) Cocaine-induced locomotor activity is enhanced by exogenous testosterone. Physiology & Behavior 76:4-5, 605-609
    CrossRef

  45. 45

    Ann-Sophie Lindqvist, Pia Johansson-Steensland, Fred Nyberg, Claudia Fahlke. (2002) Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behavioural Brain Research 133:1, 21-29
    CrossRef

  46. 46

    P. Le Greves, Q. Zhou, W. Huang, F. Nyberg. (2002) Effect of combined treatment with nandrolone and cocaine on the NMDA receptor gene expression in the rat nucleus accumbens and periaqueductal gray. Acta Psychiatrica Scandinavica 106:s412, 129-132
    CrossRef

  47. 47

    Graham Bolding, Lorraine Sherr, Jonathan Elford. (2002) Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction 97:2, 195-203
    CrossRef

  48. 48

    J Smith, D L Dahm. (2000) Creatine use among a select population of high school athletes.. Mayo Clinic Proceedings 75:12, 1257-1263
    CrossRef

  49. 49

    Jorge Torres-Calleja, Ruth De Celis, Marco Gonzalez-Unzaga, Nieves Pedrón-Nuevo. (2000) Effect of androgenic anabolic steroids on semen parameters and hormone levels in bodybuilders. Fertility and Sterility 74:5, 1055-1056
    CrossRef

  50. 50

    Pia Johansson, Ann-Sophie Lindqvist, Fred Nyberg, Claudia Fahlke. (2000) Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacology Biochemistry and Behavior 67:2, 271-279
    CrossRef

  51. 51

    Alan D. Rogol. (2000) Sex steroid and growth hormone supplementation to enhance performance in adolescent athletes. Current Opinion in Pediatrics 12:4, 382-387
    CrossRef

  52. 52

    Benjamin D. Phillis, Rodney J. Irvine, Jennifer A. Kennedy. (2000) Combined cardiac effects of cocaine and the anabolic steroid, nandrolone, in the rat. European Journal of Pharmacology 398:2, 263-272
    CrossRef

  53. 53

    Charles E. Yesalis, Michael S. Bahrke. (2000) Doping among adolescent athletes. Best Practice & Research Clinical Endocrinology & Metabolism 14:1, 25-35
    CrossRef

  54. 54

    M.T Arnedo, A Salvador, S Martinez-Sanchis, E Gonzalez-Bono. (2000) Rewarding Properties of Testosterone in Intact Male Mice. Pharmacology Biochemistry and Behavior 65:2, 327-332
    CrossRef

  55. 55

    Richard E. Harlan, Harold E. Brown, Cheryl S. Lynch, Deborah D'Souza, Meredith M. Garcia. (2000) Androgenic–anabolic steroids blunt morphine-induced c-fos expression in the rat striatum: possible role of β-endorphin. Brain Research 853:1, 99-104
    CrossRef

  56. 56

    Michael S. Bahrke, Charles E. Yesalis, Andrea N. Kopstein, Jason A. Stephens. (2000) Risk Factors Associated With Anabolic-Androgenic Steroid Use Among Adolescents. Sports Medicine 29:6, 397-405
    CrossRef

  57. 57

    Jay Smith, Robert P. Wilder. (1999) 4. Miscellaneous sports medicine topics. Archives of Physical Medicine and Rehabilitation 80:5, S68-S89
    CrossRef

  58. 58

    Dianne Neumark-Sztainer, Mary Story, Nicole H. Falkner, Trish Beuhring, Michael D. Resnick. (1999) Sociodemographic and Personal Characteristics of Adolescents Engaged in Weight Loss and Weight/Muscle Gain Behaviors: Who Is Doing What?. Preventive Medicine 28:1, 40-50
    CrossRef

  59. 59

    Amanda J. Gruber, Harrison G. Pope. (1998) Ephedrine Abuse Among 36 Female Weightlifters. The American Journal on Addictions 7:4, 256-261
    CrossRef

  60. 60

    Josiah D. Rich, Brian P. Dickinson, Nathan A. Merriman, Timothy P. Flanigan. (1998) Hepatitis C Virus Infection Related to Anabolic-Androgenic Steroid Injection in a Recreational Weight Lifter. The American Journal of Gastroenterology 93:9, 1598-1598
    CrossRef

  61. 61

    Andrea Beel, Bruce Maycock, Neil McLean. (1998) Current perspectives on anabolic steroids. Drug and Alcohol Review 17:1, 87-103
    CrossRef

  62. 62

    Ellen S. Rome, Lisa A. Rybicki, Robert H. Durant. (1998) Pregnancy and other risk behaviors among adolescent girls in Ohio. Journal of Adolescent Health 22:1, 50-55
    CrossRef

  63. 63

    Michele J. Feinberg, Augustus R. Lumia, Marilyn Y. McGinnis. (1997) The Effect of Anabolic-Androgenic Steroids on Sexual Behavior and Reproductive Tissues in Male Rats. Physiology & Behavior 62:1, 23-30
    CrossRef

  64. 64

    R H DuRant, E S Rome, M Rich, E Allred, S J Emans, E R Woods. (1997) Tobacco and alcohol use behaviors portrayed in music videos: a content analysis.. American Journal of Public Health 87:7, 1131-1135
    CrossRef

  65. 65

    Gary S. Ferenchick. (1996) Validity of self-report in identifying anabolic steroid use among weightlifters. Journal of General Internal Medicine 11:9, 554-556
    CrossRef

  66. 66

    F.H. Bronson, K.Q. Nguyen, J. De La Rosa. (1996) Effect of anabolic steroids on behavior and physiological characteristics of female mice. Physiology & Behavior 59:1, 49-55
    CrossRef

  67. 67

    D. Barrón, J. A. Pascual, J. Segura, J. Barbosa. (1995) Prediction of LC retention of steroids using solvatochromic parameters. Chromatographia 41:9-10, 573-580
    CrossRef

  68. 68

    Philip W. Meilman, R. Kelly Crace, Cheryl A. Presley, Rob Lyerla. (1995) Beyond Performance Enhancement: Polypharmacy among Collegiate Users of Steroids. Journal of American College Health 44:3, 98-104
    CrossRef

  69. 69

    Xavier de la Torre, Jordi Segura, Aldo Polettini, Maria Montagna. (1995) Detection of testosterone esters in human plasma. Journal of Mass Spectrometry 30:10, 1393-1404
    CrossRef

  70. 70

    D. Barrón, J. A. Pascual, J. Segura, J. Barbosa. (1995) Prediction of LC retention of steroids using solvatochromic parameters. Chromatographia 41:5-6, 573-580
    CrossRef

  71. 71

    Linda J. Koenig, Erika L. Wasserman. (1995) Body image and dieting failure in college men and women: Examining links between depression and eating problems. Sex Roles 32:3-4, 225-249
    CrossRef

  72. 72

    Clive L. Morrison. (1994) Anabolic steroid users identified by needle and syringe exchange contact. Drug and Alcohol Dependence 36:2, 153-155
    CrossRef

  73. 73

    Robert J. Fuentes, Art Davis, Barry Sample, Kim Jasper. (1994) Sentinel Effect of Drug Testing for Anabolic Steroid Abuse. The Journal of Law, Medicine & Ethics 22:3, 224-230
    CrossRef

  74. 74

    Kirk J. Brower, Frederic C. Blow, Elizabeth M. Hill. (1994) Risk factors for anabolic-androgenic steroid use in men. Journal of Psychiatric Research 28:4, 369-380
    CrossRef

  75. 75

    ILPO HUHTANIEMI. (1994) Anabolic-androgenic steroids — a double-edged sword?. International Journal of Andrology 17:2, 57-62
    CrossRef

  76. 76

    Robert H. Durant, Carolyn Seymore Ashworth, Cheryl Newman, Vaughn I. Rickert. (1994) Stability of the relationships between anabolic steroid use and multiple substance use among adolescents. Journal of Adolescent Health 15:2, 111-116
    CrossRef

  77. 77

    Augustus R. Lumia, Kim M. Thorner, Marilyn Y. McGinnis. (1994) Effects of chronically high doses of the anabolic androgenic steroid, testosterone, on intermale aggression and sexual behavior in male rats. Physiology & Behavior 55:2, 331-335
    CrossRef

  78. 78

    (1993) Use of Anabolic Steroids among Adolescents. New England Journal of Medicine 329:12, 888-889
    Full Text

Letters